Vienna Hypothermic Oxygenated Machine Perfusion Study - Trial NCT06418165
Access comprehensive clinical trial information for NCT06418165 through Pure Global AI's free database. This phase not specified trial is sponsored by Medical University of Vienna and is currently Recruiting. The study focuses on End Stage Liver Disease,Hepatocellular Carcinoma. Target enrollment is 500 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Observational
Sponsor & Location
Medical University of Vienna
Timeline & Enrollment
N/A
Jan 01, 2018
Dec 31, 2038
Primary Outcome
Incidence of ischemic-type biliary lesions
Summary
In this observational cohort study data on all patients undergoing liver transplantation
 after hypothermic oxygenated machine perfusion at Medical University of Vienna will be
 prospectively recorded. Investigation of short- and long-term outcome in this cohort will be
 conducted.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06418165
Non-Device Trial